Option Care Health, Inc. - Common Stock (OPCH)
Healthcare › Services-Home Health Care Services
Price History
Feb 9, 2026 — May 12, 2026Investment Snapshot
- Trading 28% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 14.4% — below-average profitability
- Revenue growing at 13% annually
Option Care Health, Inc. - Common Stock (OPCH) is a Healthcare company operating in Services-Home Health Care Services, listed on the NASDAQ , with a market capitalisation of $3.1 billion . Key value metrics: P/E ratio 16.0, P/B ratio 2.30, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Option Care Health, Inc. - Common Stock — Fundamental Analysis Summary
Option Care Health, Inc. - Common Stock (OPCH) is currently trading 28% above its Graham Number of $15.48, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 16.0x.
On financial health, OPCH shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 14.4% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.86.
StockPik's composite Value Score for OPCH is 68/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
OPCH reports a thin gross margin of 19.3% (sector average: 40.1%) and a modest operating margin of 5.8%.
OPCH shows revenue growing at 13% year-over-year, with earnings declining at 2%.